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AN EVALUATION OF THE TREATMENT MODALITY AND MANAGEMENT OF
OPIOID THERAPY IN ACUTE AND CHRONIC LOW BACK PAIN INDIVIDUALS
IN RURAL SOUTHEAST

An Abstract of the Scholarly Project by
Michele R. Carey

Roughly 25 million American adults experience pain, and 23 million others
withstand severe assiduous pain that is disabling and results in decrease work
productivity, loss of quality of life and diminished health (Meldrum, 2016). Treatment of
pain, including chronic and acute low back pain includes a multidisciplinary approach
merging cognitive-behavioral, psychological and physical therapies, respite, pain coping
management and self-hypnosis (Meldrum, 2016). In 1999, pharmaceutical companies
reassured physicians that opioid pain relievers were not addictive, and the prescribing
rate began to increase (NIH, 2017).
The quantity of opioids being prescribed has quadrupled since 1999 which has led
to an increase in diversion and misuse of these medications, thereby increasing the
overdose rate from opioids. This abuse and addiction to opioids has become a crisis of
epidemic proportions in the US with deaths from overdose now a leading cause of injury
death (APSE issue Brief, 2015). The most addictive of these medications such as
hydrocodone and oxycodone, are routinely used for a variety of conditions, yet guidelines
for the prescribing of opioids suggest that alternate treatment may be equally effective
but are not being used. This opioid epidemic appears multi-factorial including incorrect
prescribing, illicit and licit drug resources and patient non-adherence.
Opioid abuse is a significant preventable public health threat challenging our
country. This educational scholarly project looks at the prescribing practices of
viii

providers in a set of clinics in Southeast Kansas. The purpose of this study was to
discover if providers within these clinics followed the recommended CDC guidelines.
The guidelines include a trial of non-pharmacological, non-opioid therapy to manage
acute and chronic back pain before initiating opioid therapy, whether they obtained a
controlled substance agreement, checked the prescription drug monitoring program
and obtained a urine drug screen prior to prescribing opioids. The information
obtained from the clinics was then compared to other regions in Southeast Kansas.
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CHAPTER I

Introduction

Roughly 25 million American adults experience pain, and 23 million
others withstand severe assiduous pain that is disabling and results in decreased
work productivity, loss of quality of life and diminished health (Meldrum, 2016).
Treatment of pain including acute and chronic back pain should incorporate a
multidisciplinary approach merging cognitive-behavioral, psychological and
physical therapies, respite, pain coping management and self-hypnosis (Meldrum,
2016). The primary cause of accidental deaths in the United States is drug
overdose with opioid addiction as the driving force (ASAM,2016). Four out of
five individuals that use drugs, often begin with opioid pain relievers and then
turn to the use of heroin due to cost and ease of buying. (ASMA, 2016).
Description of Clinical Problem

In 1999, pharmaceutical companies reassured physicians that opioid pain
relievers for the use of acute or chronic pain, were not addictive, and the
prescribing rate began to increase (NIH, 2017). The quantity of opioids being
prescribed has quadrupled since 1999 which has led to an increase in diversion
and misuse of these medications. In addition, this has increased the overdose rate
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from opioids, yet the amount of pain that Americans have reported has not
increased (NSDUH, 2014).
This abuse and addiction to opioids has become a crisis of epidemic
proportions in the US with deaths from overdose now a leading cause of injury
death (APSE issue Brief, 2015), creating a critical and perplexing public health
problem. The most addictive of these medications are routinely used for a variety
of conditions, yet guidelines for the prescribing of opioids suggest that alternate
treatment may be equally effective. Alternate therapies are not routinely used:
non-pharmacological approaches with non-steroidal anti-inflammatories and
acetaminophen coupled with physical therapy and self-care instructions. A
fundamental concern with prescription opioid associated morbidity and mortality
is the significant number of individuals that have reported use of nonmedical
prescription drugs, without a prescription or use to obtain a reaction or experience
the drug causes (APSE Issue Brief, 2015). This opioid epidemic appears multifactorial including incorrect prescribing, illicit and licit drug resources and patient
non-adherence.
Significance

Opioids such as morphine, methadone, oxycodone and hydrocodone are
the most widespread drugs. Opioid abuse is a significant preventable public
health threat challenging our country. To date, the death toll has exceeded more
than 600,000, with 180,000 more predicted by 2020 (Gostin et al., 2017).
According to the American Society of Addiction Medicine (ASAM, 2016), 20.5
million US residents twelve years of age or more had a substance abuse malady in
2

2015, two million were dependent on prescription pain relievers, 591,000 engaged
in substance abuse that included heroin, and they predict that more than 20% of
persons that abuse heroin will develop an addiction to opioids (AMSA, 2016). In
response to this situation, President Trump has declared a national emergency on
the drug addiction and opioid crisis. The national emergency affirmation
acknowledges community health powers, activates resources and authorizes
advanced tactics to reduce a public health crisis that is accelerating rapidly
(Gostin et al., 2017).
Cultivating a change in how opioids are ordered with clinical practice
guidelines safe-guards clients with more secure and successful chronic pain
treatment and minimizes the risk of opioid use disorder (CDC, 2017). Improving
public health prevention nation-wide would aid in a reduction of death and
morbidity and be cost effective as well (Gostin et al., 2017). The CDC
recommends nonpharmacological and nonopioid pharmacologic treatment as the
desired therapy for individuals with unceasing pain.
Constant pain afflicts more than 10% of US adults and millions are treated
with prescription opioids, making opioids the most ordered prescription
pharmaceuticals; they are also highly addictive (Gostin et al., 2017). Mortality
related to opioids has risen more than 150% from 21,088 in 2010 to 33,091 in
2015, reducing the life expectancy of users (Gostin et al., 2017). Teen overdose
deaths went from 649 in 2014 to 772 in 2015; an increase of 19%. The rampant
use of opioids costs the United States more than $90 billion in 2016 (Gostin et al.,
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2017). Patients in the US use almost 100% of all hydrocodone and more than
80% of all oxycodone worldwide (Manchikanti, 2013).
Close to 250 million opioid prescriptions for pain were written by
providers in 2013, and one out of four patients on prolonged opioid treatment in
primary care were struggling with opioid use disorder (CDC). During the data
collection, the CDC found 20,000 deaths in 2015 related to prescription opioids
equaling about 62 deaths per day. The National Center for Health Statistics
(NCHS, 2015) revealed the sales of opioid painkillers quadrupled from 19992010, and deaths related to opioids had also tripled from 1999-2012. Data
collected in 2015 revealed that $250,000 adolescents were nonmedical users of
pain relievers, and nearly half were addicted to pain relievers (ASMA, 2016).
The state of Kansas is comparable to the national numbers with KDHE
reporting a threefold increase in drug hospitalization from 1999-2009, with deaths
caused by opioid analgesics rising threefold from 1999-2010 (KDHE, 2014). The
age-adjusted rate for acute drug poisoning among Kansas residents was slightly
lower than the CDC’s Healthy People 2020 target at 10.6 deaths per 100,000
compared to 11.3 per 100,000 (KDHE, 2014). Southeast Kansas rose above all
states with the highest age-adjusted rate of death from acute drug poisoning in the
state, with 13.4 deaths per 100,00 between 2009-2013, while Southwest Kansas
having the lowest age-adjusted rate of 5.7 deaths per 100,00 (KDHE, 2014). Men
had an age-adjusted rate of 11.6 per 100,000 compared with women at 9.6 per
100,000, while white non-Hispanics held the highest age adjusted death rate at
11.7 per 100,000 (KDHE, 2014).

4

Opioids, such as morphine, methadone, oxycodone and hydrocodone were
the most widespread drug, with 41.1% of drug related deaths, followed by
Pyschostimulants, which include methamphetamine were the second most
prevalent, at 7.5% of deaths between 2009-2013. Because a significant number of
drug deaths were the result of multiple drugs, known and unknown, or at least
alcohol and one drug, meaning that any drug death could be due to more than one
drug as a contributor, these numbers do not equal 100% (KDHE, 2014).
APRNs are among the healthcare professionals that are in a position of
changing these numbers by thwarting improper access. To ensure sound
appropriate prescribing, APRNs must consider using these drugs for legitimate
purposes and curtail dangerous practices that are contributing to this growing
crisis. To effectively incorporate safe practice, actions must focus on both the
prescribers and the identification of high-risk patients while increasing the
monitoring of prescription drugs and the sharing of data among providers.
Clinicians face daunting tasks in assessing pain levels in clients and choosing
appropriate nonpharmacologic and pharmacologic treatments. Once the decision
to begin opioid therapy has been made, appropriate monitoring of therapy for
abuse prevention and diversion can be equally intimidating (Carter, 2017).
Description of Clinical Issue

Pain can affect every individual and it is challenging yet unique for each
person and afflicts the lives of more than 100 million Americans (Institute of
Medicine, 2011). Knowledge and educational limitations of health care
professionals are equally challenging when treating pain. The Institute of
5

Medicine (IOM) 2011 reports that only half of primary care providers (PCPs) feel
somewhat prepared while 27% report feeling somewhat unprepared or
underprepared to treat individuals with chronic pain.
Prior to 2016, when the CDC sent out 12 suggestions for opioid use in
chronic pain, there were relatively few guidelines to which providers could refer.
These guidelines include: use of nonpharmacologic therapy and nonopioid
pharmacologic therapy as first line treatment to include ibuprofen, Tylenol, ice,
heat, physical therapy or a combination of each, education provided to patients
regarding goal expectation and opioid use-risks versus benefit, if an opioid was
prescribed, was it before or after conservative management, choice of opioid and
dose provided, use of a controlled substance agreement, use of prescription drug
monitoring programs (PMDP) and periodic drug screenings to verify compliance
and deter abuse and misuse.
The CDC’s recommended guidelines mirrored guidelines made by the
American Society of Interventional Pain Physicians Guidelines (ASIPP, 2017)
related to the safe, responsible, and effective prescription of opioids for
unrelenting non-cancer pain. Both the CDC recommendations and the guidelines
put out by ASIPP state that nonpharmacological and nonopioid pharmacologic
therapy are the desired choice for prolonged pain. The CDC recommendations
are voluntary and do not replace the clinical decision-making discussion between
the provider and the patient according to the situation, functional status and
quality of life. The ASIPP guidelines are recommendations on the actions that
may or may not be taken in various situations when it comes to chronic opioid
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therapy and different groups of people. The recommendations are aimed at family
practice, internal medicine, nurse practitioners and physician assistants, who are
among the top four prescribers of opioids (Laxmaiah et al., 2017).
The US financial burden for more than 100 million Americans suffering
from pain is estimated to be more than $500 billion per year, and this number
does not include children suffering with pain and those in long-term care
facilities. Back pain ranks in the top five most common complaints for all
provider visits. Approximately, one fourth of adults expressed having back
“pain” a minimum of one day in the last ninety days (Chou et al., 2007). Many
occurrences are self-limiting, but one third of people have persistent back pain
one year after an initial event, and one out of five persons indicate significant
activity limitations (Chou et al., 2007). Many individuals seeking medical care
for back pain are unable to link it to a specific cause or abnormality.
Impairment in daily functions of life related to chronic pain is a leading
cause of outpatient visits, specifically, chronic back pain (Keller, 2012).
Individuals that suffer agonizing injuries often develop longstanding chronic pain
(Keller, 2012). Some people will develop chronic pain syndrome with is a
constellation of symptoms including, sleep disturbance, emotional lability,
depression, isolation from other, diminished functional capacity and character
changes (Keller, 2012). Chronic pain unrelated to malignancy is one of the most
common and incapacitating medical conditions that is both contentious and
convoluted to control (Volkow, 2016). Low back pain is concomitant with
elevated levels of disability and has a one-year prevalent episode of 38% in the
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overall population (Azevado, 2015). Acute low back pain is pain lasting less than
six weeks duration and becomes chronic low back pain when it exceeds three
months duration.
Complex treatments, diverse approaches and available resources that can
be utilized in determining acceptable practice prove to be challenging for
providers. Each case is evaluated on its merit and circumstances. Clinicians need
to consider both the benefit and the risk of opioid therapy for the patient,
identifying outcome expectations with the client’s current level of function. The
benefit of receiving opioid therapy should be weighed against the potential risk,
including sedation, tolerance, dependence and confusion. Evidence supports
common safety practices and indicators provide guidance in the assessment,
intervention and safe prescribing of opioids. Providers cannot be responsible for
patient actions once they leave the office, but it is the providers’ obligation to
make opioid use as safe as possible. Standards of care (SOC) have been
implemented and endorsed to protect the patient and the public from opioid
misuse and the provider is responsible for adhering to these standards (Hudspeth,
2016).
Screening tools are useful in identifying persons at high risk for abuse or
medication misuse. These tools are aimed at identifying individuals who
currently use substances such as tobacco or alcohol, individuals who use other
people’s medications, have mental or mood disorders, those experiencing
problems with employment or in their family circle and individuals with a
pertinent childhood history of abuse and neglect or convicted of any related
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crimes such as driving under the influence. There are multiple screening tools
such as Opioid Risk Assessment (ORT), and the National Institute on Drug Abuse
(NIDA), and SOAPP-R (Screener and Opioid Assessment for patients with Painrevised), and these tools are available as apps that can be downloaded to a smart
phone for ease of use.
It is important to remember that risk assessment tools are not wholly
consistent or accurate in their prediction of opioid misuse or abuse. Risk
evaluation and mitigation strategies (REMS) have been approved by the Food and
Drug Administration (FDA) but have not been evaluated to be effective (Dowell
et al., 2016). A favorably sensitive determination for persons at risk for
medication misuse was found in a single question related to how often the person
has used alcohol, tobacco, illegal drugs and prescription drugs for nonmedical
reasons. Providers must also remember that high-risk individuals can still receive
opioid therapy with appropriate management and follow up.
Providers have an honorable and legal duty to care for patients including
management of their pain, but pain is subjective and creates a sticky predicament
for providers (Reidl, 2014). There is great debate among government entities on
the appropriate treatment of pain with the use of opioids and the identification of
those at high risk for use and abuse. Known factors contributing to abuse and use
include, poverty, unemployment, work injuries, and a lack of education
(Laxmaiah et al., 2017). Highly trained NPs or PAs will know the best treatment
for pain, how to initiate therapy, and monitor such therapy, when additional
testing is needed for interventions and when to refer to an appropriate specialist
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(Carter, 2017), and yet a lack of education and preparation of providers when
evaluating and monitoring a patient on opioid therapy coupled with known risk
factors of abuse and use among patients contributes to the ever-growing opioid
epidemic. To fully understand the scope of the opioid epidemic in rural Southeast
Kansas, an evaluation will be completed of how opioids are prescribed and
whether the appropriate and current suggested recommendations and guidelines
are being used by clinicians in rural Southeast Kansas.
Specific Aim/Purpose

The goal of this scholarly project was to discern the quantity of opioid
prescription written for acute and chronic back pain in rural Southeast Kansas
among multiple clinics. In addition, this project attempted to discover whether
CDC guidelines had been followed such as the use of UDS and PMDP, and if
appropriate monitoring of the patient was done in these clinics in Southeast
Kansas. This project also noted if clinicians attempted nonpharmacological and
nonopioid therapy to manage acute and chronic back pain before they initiated
opioid therapy. The data gathered was then compared to how Southeast Kansas
ranks in the number of opioids prescribed compared to other regions in Southeast
Kansas.
Theoretical Framework

There are two theoretical frameworks that were used in this scholarly
project, Patricia Benner’s from Novice to Expert Model and Nola J. Pender’s
Health Promotion Model. Knowledge is gained through education, training and
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adequate resources that prepare clinicians to make evidenced based decisions to
ensure the best treatment for their clients. This mimics Benner’s (1984) model,
From Novice to Expert, where clinicians develop skills and understanding over
time based on a strong foundation in education and personal experiences.
Clinicians can gather knowledge via research and clinical practices. Nurses must
initially learn what to look for and how to intervene in a situation, but as they
move along through their career and consistently gather knowledge, they move
from a novice to an expert in nursing. Nurses returning to school for further
education follow the Novice to Expert plan as well, though they are already
practicing nurses. These skills are gained through education in a formal setting,
education in practice, research and clinical practice throughout one’s career.
Nora J. Pender’s 1982 Health Promotion Model is also appropriate for this
scholarly project as she considers how surroundings influence the choices
individuals make and how people search for ways to achieve their dream, but
obstacles often hinder or entice individuals with items that appear promising.
Clinicians can improve the health of individuals by being role models and through
education with health promotion. Southeast Kansas has many individuals living in
poverty, and if surroundings influence choices and opioid use is higher among
those in poverty areas, then becoming stewards of the community through health
promotion will allow clinicians not only learning experiences but the opportunity
to be role models and improve the life of individuals before chronic illness or
poor choices take control.
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Figure 1. Patricia Benner’s from Novice to Expert Model Figure
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Figure 2. Nola Pender’s Health Promotion Model
Research Questions

1). Are clinicians in selected clinics in rural Southeast Kansas prescribing opioids using

the current CDC recommendations and guidelines?

2). How does Southeast Kansas compare to other regions in Kansas regarding the

number of opioids written by providers?
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Definition of Key Terms

The key terms for the project include:
Chronic pain- In this project, chronic pain refers to pain lasting longer than twelve weeks
(Chou et al., 2007).
Acute back pain refers to pain lasting less than twelve weeks (Hallegraef et al., 2013).
Opiate medications are powerful prescription medications that are used to reduce pain
(UpToDate, 2017).
Opioid Analgesics include: Hydrocodone, Oxycodone, Fentanyl and Morphine Sulfate
which bind opioid central nervous system (CNS) opioid receptors leading to inhibition of
ascending pathways altering an individual’s perception and response to pain (UpToDate,
2017).
A “Nurse Practitioner is defined as a certified registered nurse with advanced nursing
credentials displayed through formal education and training” (American Medical
Association [AMA], 2009, p.8).
Physicians Assistants are defined as restricted licensed primary care providers (AMA,
2009).
Addiction is a lingering brain disease with frequent relapses characterized by habitual
pursuit of drugs and use, regardless of dangerous outcomes (Volkow, 2014).
Tolerance is an adaptive consequence of an exposure to a drug which leads to a need for
increased doses to obtain adequate pain control (Leonardi et al., 2015).
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Logic Model

The components of the logic model for this project included inputs,
activities, outputs and outcomes as outlined in Table I. Using a descriptive
retrospective chart review analysis of data, prescribing practices and treatment
modalities of physicians, nurse practitioners and physician assistants revealed
how different data outputs can improve outcomes by revealing safe prescribing
practices, improved provider collaboration, identifying persons at high risk for
abuse potential using CDC guidelines, use of a PDMP and random UDS which
will lead to improving patient safety.
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Table 1. Logic Model
Inputs
Activities

Outputs

Outcomes (Impact)
Short Term

Physicians

Descriptive
Retrospective
Chart Review

Use of CDC
guidelines

Nurse
Practitioners Data Analysis

Obstacles to
use of
guidelines

Physician
Assistants

Safe Prescribing

Medium Term

Long Term

Use of
CDC guidelines

Prescribing
Practices

Initiators of
guidelines

Treatment
Modalities

Provider
Collaboration

Patient
Safety

Improved
Provider
Collaboration

Identification for
High risk
Abuse Potential

Data
Comparison
among
Providers

Use of PMDP
Use of random
UDS

Improved
Patient Education

Improved Provider
Education
Comparison
across Kansas

Summary

Chronic pain is a public health issue and a medical condition that denotes
physical, cognitive and emotional consequences (Leonardi, 2015). It is a
multifactorial concern that often goes under-treated or untreated and is the
number one presenting complaint in various practice settings from the emergency
room to primary care (Carter, 2017). Opioids can safely be used for unrelenting
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pain management, yet the rate of addiction and overuse of opioids has resulted in
an epidemic in the United States with ramifications that can last a lifetime.
NPs and PAs are capable of pain management and must include a
multidisciplinary, multimodal approach but they need additional formal training
in both management of pain and pain medications coupled with clear guidelines to
follow during the initiation of and monitoring of pain management. While many
states require education for pain management, it will take more than two hours of
continuing medical education to understand both how to treat and the risks of the
medications that are being used (Raj, 2017).
Treatment of chronic pain is vital both clinically, and ethically and opioids
have a place as a treatment modality however, pain is a complex disorder and
requires a team approach. NPs and PAs must feel comfortable with appropriate
training and guidelines along with risk assessment tools for the safe prescribing of
opioids in pain management. Provider practices can be influenced by where they
practice, and their knowledge and comfort with pain management modalities
which include opioid therapy, can allow providers to deliver safe and effective
care.
Opioid use, abuse, and diversion has reached epidemic proportions in the
US. To attempt to correct this issue, this researcher is hoping to find out if
providers are contributing to the problem. Pain is the fifth vital sign and
providers are expected to adequately treat a patient’s pain (Hudspeth, 2011);
however, provider anxiety when prescribing opioids may inadvertently contribute
to the crisis. Non-pharmacological treatment modalities have been noted to be
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successful in the treatment of acute and chronic pain, yet more and more
individuals and prescribers are relying on opioids which exacerbates the problem.
This researcher hoped to determine the current prescribing practices of
acute and chronic back pain patients by providers in rural Southeast Kansas. This
researcher hoped to elicit if providers had prescribed opioids by following the
recommended CDC guidelines using PMDPs and urine drug screening. The use
of this data will improve provider compliance with the use of evidence-based
opioid prescribing and monitoring for patient abuse and diversion. Increasing
education of the patient on the pathophysiology of pain and appropriate therapies
may begin to decrease the opioid consumption in the US, reducing the economic
burden that it currently holds.
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CHAPTER II

Introduction Literature Review

A review of the literature was performed utilizing the following search
criteria: opioid abuse and misuse, therapy for chronic low back pain, pain
management with the use of opiates, best practice evidence in pain management,
tools for treating back pain, the addict’s point of view, prescribing practices
among providers and education in treatment of back pain, the public opinion on
opioid use, substance abuse, pain management and provider knowledge on pain
management. The review of literature will include proposals from medical
professionals in diverse specialties to determine collective thoughts of
professionals involved in the treatment of pain. This literature will incorporate
recommendations from the CDC, the FDA and the American Society of
International Pain Physicians (ASIPP) concerning appropriate opioid prescribing
practices, short and long acting opioid use and when it is appropriate to continue
long term opioid therapy.
This literature review suggests that there is a lack of knowledge and
training in various pain treatment areas and how best to treat non-malignant
cancer pain with opioids (Harris et al., 2008). As chronic pain (CP) is the most
common reason people seek medical care (Leonardi et al., 2015), nurse
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practitioners (NPs) and physician assistants (PAs) are asked to manage chronic
pain in the primary setting yet face formidable challenges in selecting appropriate
nonpharmacological and pharmacologic therapies, when a patient needs an opioid
and then how to provide ongoing monitoring to curtail abuse and diversion
(Carter, M., 2017).
Musculoskeletal disorders are the most frequent cause of disability in
developed countries and account for about 3% of the cost of the gross domestic
product in the United States (Watson & Shay, 2010). Low back pain is a familiar
complaint and exemplifies a substantial burden in patient suffering and costs
(Watson & Shay, 2010). As musculoskeletal disorders increase as individuals
age, it is logical to presume that individuals with chronic disability will also
increase. Low back pain is prevalent in about 44-49% of the population with a
lifetime prevalence between 51-84% (Watson & Shay, 2010).
Research suggests primary care providers receive inadequate education on
how to appropriately manage acute and chronic back pain. This includes the
appropriate use of non-pharmacologic treatment modalities, non-opioid
prescriptions and safe prescribing tools, as well as monitoring opioid use
(Dowling & Denisco 2012). Opioid prescribing among ambulatory care settings
doubled from 8% in 1980 to 16% in 2000 (Manchikanti & Hirsch, 2013). Lack of
instruction and preparation in treating pain and opioid prescribing has been found
to increase the stress level and fatigue among primary care providers and they are
concerned with the misuse of opioids. Research also noted four categories in
prescribing errors when opioids are used including: insufficient assessment for
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secure and successful opioid use, failure to supervise compliance, inappropriate
choice of opioid and lack of regard for comorbidities (Manchikanti & Hirsch,
2013).
Pathophysiology and Epidemiology of Pain

Improper selection of opioids suggests a lack of knowledge on pain itself.
Chronic pain is a complex interaction of nociceptive, neuropathic or mixed
pathogenic systems (Leonardi et al., 2015). Nociceptive pain stems from
stimulation of the primary afferent nociceptors in the peripheral nervous system in
response to some assault on the system. This response is sent to the central
nervous system which allows the body to recognize damage. Endogenous opiates
with serotonin and noradrenaline and others incorporates the perception of pain
and thus becomes a balance of stimulation and inhibition that depends on
emotional and behavioral influences (Leonardi et al., 2015). Neuropathic pain is
derived from injured tissue that withstands a primary injury or dysfunction in the
central nervous system. The pain may occur centrally or peripherally, but
syndromes will differ depending on involved fibers. Neuropathic pain is a
common ailment in primary care and can be disabling (Leonardi et al., 2015).
Data has revealed that chronic noncancer patients are not an identical group
and often present with biological, psychological and social issues convoluted by
depression, anxiety, somatoform disorders and substance abuse (Leonardi et al
2015). An accurate diagnosis of chronic pain means clinicians need to
characterize the nature of the discomfort and the pathology of pain, which are
multifarious often with mechanisms that overlap (Leonardi et al., 2015).
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Addiction is a recurring, relapsing brain disorder categorized by drug
seeking and use regardless of harmful outcomes. Addiction results from
interactions between biological and environmental factors, which increases the
concerns regarding safety, efficacy and appropriate use of opioids in unrelenting
noncancer pain clients (Leonardi et al., 2015).
Pain Management Education

The Association of American Medical Colleges created a survey in 2001
demonstrating that less than 4% of medical institutions mandate pain management
instruction (Bair, 2011). Most patients suffering from acute and chronic pain are
treated by their primary care provider due to a lack of pain specialists (Bair,
2011). Clinical practice guidelines (CPG) already developed focus on
monitoring, early detection and treatment of problems and conservative dosing
and improved patient treatment, yet they are not consistently utilized (Trafton et
al., 2010). Training of pain management is often fragmented and learned on the
job due to the lack of formal education and training (Bair, 2011).
Chronic pain management is complicated even for pain specialists and is
compounded by an individual’s comorbidities. Providers that do not specialize in
pain management receive little training in pain and opioid management in the
primary care setting, where pain is only a piece of serious conditions that need
addressed during a visit (Trafton et al., 2010). Clinical mentoring for nurse
practitioners often does not include hours dedicated to pain management and
orthopedic specialties (Hudspeth, 2011), which leads to a lack of knowledge and
skills in accurate diagnosing and treatment of patients with musculoskeletal pain
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(Bair, 2011). An appropriate approach to pain management is through matching
the analgesics mechanism of action to the underlying pathophysiology of the pain
(Raffa & Pergolizzi, 2014) providing clinicians with relevant knowledge of pain
and offering clinical expertise to raise assurance in managing unceasing pain
(Bair, 2011).
Chronic Pain, Opioids and National Surveys

Opioids are generally used for treatment of chronic pain often at doses that
surpass current recommended guideline doses (Gomes et al., 2011). Addiction
results from the inherent reinforcing properties of opioids and psychological,
social and physiologic factors of individuals (Fishbain et al., 2008). Unrelenting
pain that drives individuals to seek care is not different among states; however,
prescribing rates for opioids vary significantly across states (NPA, 2012). In the
states with the highest prescribing rates, health care providers penned almost
triple the opioid prescriptions per person than providers in lower prescribing
states with lower socioeconomic status and higher levels of unemployment as
contributing factors (NPA, 2012). Economic depression may contribute to the
increase in prescription, sales, abuse, overdose and death of opioids (Galewitz,
2017). Where a clinician practices often influences how they prescribe and may
be influenced by their knowledge and comfort with pain management and
understanding of treatment modalities which include opioid therapy (NPA, 2012).
Among individuals that abuse opioids, many get them free from family and
friends, and those at a higher risk for overdose obtain them differently than those
who use opioids less frequently. Of those that use opioids, 27% of individuals use
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their own prescription, 26% obtain them from friends and family for free, 23%
buy them from friends and family and 15% obtain them from drug dealers. The
individuals that have a higher risk for overdose are four times more likely to
purchase from a drug dealer or stranger (CDC, 2017).
Current Recommendations
Unremitting pain is a biopsychosocial disorder that compels integrated,
multimodal and interdisciplinary management, all elements of which should be
evidence-based (Choo, 2017). The treatment for pain classes such as neuropathic
pain and non-neuropathic pain vary, and clinicians need to differentiate between
nociceptive and neuropathic pain to appropriately treat the patient (Stones et al.,
2016).
Efforts to initiate an integrated multidisciplinary approach to treatment is
often met with resistance with patients refusing to participate in physical therapy
(Choo, 2017). Patients suffering from pain will have difficulty with simple life
tasks such as washing dishes, using the bathroom and engaging in hobbies, which
then affects not just social and physical well-being but psychological as well
(Choo, 2017). Finding strategies that provide patient autonomy and normalcy
may improve their control over their pain.
The American Academy of Pain Medicine (AAPM) has acknowledged
that safe pain treatment amid primary care providers is ranked as one of the top
five concerns (AAPM, 2012). Treating chronic pain is complex due to the
perception of pain and its trajectory. Providers should begin looking at pain with
an improved sense of understanding of the patients need, with the key principle

24

being that doing nothing is better than causing harm with medications (Knaggs &
Stannard, 2017).
Opioid therapy has been increasing since the 1990’s for unrelenting
pain, yet recent research has questioned the safety and efficacy of opioid use for
unrelenting pain not related to cancer, due to the increased risk of tolerance,
addiction and hyperalgesia (NIDA, 2016). Opioid abuse and dependence are
chronic, extensive multifactorial disorders that lead to detrimental effects on
individuals and society. A basic understanding of the mechanism behind the
disorder can aid in identification of management strategies to prevent and treat
opioid related disorders (Mistry et al., 2014).
The Joint Commission on Accreditation of Healthcare Organizations
developed new measures to advance pain control, fostering the use of pain scales
and tools, using pain as the fifth vital sign and raising opioid prescribing and
pharmaceutical opioid accessibility for nonmedical use and overdose (Paulozzi,
2011).
Providers report inadequate training when managing chronic pain,
especially in individuals with aberrant behavior (Calcaterra et al., 2013).
Controlling pain is a central issue in the US with healthcare providers and policy
makers attempting to abate undesirable effects of increased access to prescription
opioids while still providing adequate pain control (Brady et al., 2016).
Legislative Policy

Between 1999-2010, an analysis of spine care in the US, showed low use
of nonpharmacologic therapies in clinical practice. Commonly prescribed high25

risk medications such as opioids promotes concern due to the known issues with
safety and effectiveness (Krein et al., 2016). Drug addiction is a social problem
with individuals feeling the need to take regular doses of substances to feel good
(Beneitez & Gil-Alegre, 2017). Slashing the drug supply will not stop this trend;
however, it is preferred that people be able to confront their lives and learn coping
mechanisms during stressful situations without drugs, and therefore education is
so important when it comes to healthcare (Beneitez & Gil-Alegre, 2017).
The National Health Institute is an influential agency that is leading the
charge to discover ways to thwart the misuse of opioids, handle opioid use
disorders and control pain. This initiative is working toward a partnership with
pharmaceutical corporations and educational research agencies to cultivate secure,
effective and non-addictive strategies for pain management. The initiative also
looks for inventive ways to treat opioid use disorders, improve deterrence and
reversal interventions to save lives while providing recovery support. Refining
the way in which providers prescribe opioids through clinical practice guidelines
will guarantee clients have access to safer, more useful treatment of unrelenting
pain while lowering the risk of opioid use disorder (CDC, 2017), and clinicians
are committed to using evidence-based practice to identify, interpret and apply
findings to individuals. Improving public health prevention nationwide would aid
in a reduction of death and morbidity and be cost effective (Gostin et al., 2017).
The CDC recommends nonpharmacological and nonopioid pharmacologic
treatment as the desired treatment for individuals with chronic pain.
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Drugs will exist continually, and the United States Federal Drug
Administration (USFDA) program is educating providers on appropriate opioid
prescribing practices, how to identify patients suited for opioid therapy, and how
to properly educate individuals regarding use of opioids, storage and disposal
(Beneitez & Gil-Alegre., 2017). In 2010, the CDC noted that opioids were
responsible for more than 16,000 deaths out of 40,00 drug overdose deaths and as
a result, the FDA published the “Guidance for Industry Assessment of Abuse
Potential Drugs” explicitly looking at the study and improvement of new
pharmaceutical technologies with the goal of reducing drug abuse (Beneitez &
Gil-Alegre, 2017).
In 2016, the CDC came out with a set of guidelines to aid providers in
their decision making regarding opioid therapy. The CDC’s guidelines have three
main focuses: initiation of or the continuance of opioid therapy for prolonged
pain; choice of opiate, dosage, length of use, follow up, discontinuation and
assessment of risk; and addressing harms of opioid use.
The foundation for development of these guidelines was the result of
provider trepidations about opioid drug misuse, overseeing patients with
protracted pain, apprehension regarding dependence and reports of inadequate
education in prescribing opioids (CDC, 2016). Clinician knowledge, prescribing
practice changes and improved patient health benefit can be achieved with the use
of clinical practice guidelines concentrating on prescribing opioids (CDC, 2016).
The CDC is not the only professional organization to release new
guidelines. The American Pain Society/American Academy of Pain Medicine,
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2009. Washington Agency Medical Directors Group 2015, and the US
Department of Veterans Affairs/Department of Defense 2010 have also created
guidelines. Each of the guidelines impart mutual components including dose
titration and risk mitigation strategies, yet there is significant variance in specific
recommendations which may not reflect evidence-based material (CDC, 2016).
Evidence based guidelines can enhance care and improve patient safety while
decreasing misuse of opioids (CDC, 2016).
Opioids are an important piece of acute pain treatment for moderate to
severe pain, but hazards for chronic use do exist (Streltzer et al., 2008). The
American Academy of Addiction Psychiatry came out with a set of guidelines
when using opioids in unrelenting nonmalignant pain for those who believe in
their efficacy, hoping to maximize benefits and minimize harm (Streltzer et al.,
2008). Among their recommendations they note that some state medical licensing
boards believe the customary practice when using opioids is a reduction in
symptoms and improvement in functioning, observing that high dose opioids have
not been proven to be effective, and when used long term they create and increase
in hyperalgesia or pain sensitivity (Streltzer et al., 2008).
A two to four weeks trial of opiates for the treatment of acute pain has
been noted among providers (Tavernise, 2016), and research has noted that there
is some benefit in pain management if opiates are used less than twelve weeks
(Dowell et al., 2016). Current recommended guidelines are to treat pain with
ibuprofen and aspirin as a first line modality with opiates being used for three
days but no longer than one week (Tavernise, 2016). Dowell, Haegerich, &
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Chou, (2016), found limited research that opioids are beneficial for long term
treatment of pain. Habitual opioid use disorder, death and overdose was implied
when opioids were given for acute back pain (Dowell et al., 2016).
Public concern and awareness regarding the negative impact of
prescription abuse and misuse has grown. There has been little research done on
how provider’s views related to the epidemic influences the efforts to address the
issue, while public health policy makers and researchers study intervention tactics
(Wright et al., 2016).
Simple strategies outlined by state policymakers include the electronic
physician order entry system and the prescription drug monitoring systems
(PDMP) which document and monitor the use of schedule II-V narcotics (Wright
et al., 2016). Although these systems are primarily for tracking prescribing
practices and note potential provider shopping, many of the systems are quite new
in their development (Wright et al., 2016). Regardless of the system used,
research needs to look at how providers view the drug epidemic and how these
beliefs influence their practice (Wright et al., 2016).
There have been mixed feelings among providers regarding the strategies,
as some providers feel that these governmental regulations intrude their practice.
PMDPs often offer beneficial information back to prescribers to facilitate
improvement in the quality of their day to day clinical decision making, but they
do expand governmental oversight into clinical practices (Wright et al., 2016).
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Patient’s Satisfaction and Current Clinical Recommendation

Cautionary use of opioids for pain therapy becomes a challenge as pain
decreases. Withdrawal by the patient may be uncomfortable; and, the prescribing
provider maybe inexperienced in the titration of the opioid, which may lead to
continued use of opioids even if benefits are minimal and risks are high for
continued use (Streltzer et al., 2009). One guideline by the American Academy of
Addiction Psychiatry allows the provider and patient the use of opioids if they
believe them to be effective but encourages the thought of how opioids can harm
some and how diversion may occur (Streltzer et al., 2009). Abuse, misuse, opioid
overdose and death have spurred the CDC, National Center for Injury Prevention
and Control (NCIPC), National Institute for Drug Abuse (NIDA) and the
Substance Abuse and Mental Health Services Administration (SAMHSA) to
develop current recommendations after reviewing common practice guidelines
(Dowell et al 2016).
Among the eight guidelines the common practices include a complete
physical exam, thorough pain record, medical history, family and social history,
urine drug screening and a discussion about the appropriate treatment course. The
treatment course should include a discussion regarding use of opiates at the lowest
dose once alternative treatments have been unsuccessful; the implementation of a
controlled substance agreement, and a method to monitor treatment and pain
progress with a plan for safe, effective discontinuation of opioids (Dowell et al.,
2016).
Another consideration is the prevalence in which opioids are being
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diverted, with many of the diverted opioids from prescriptions that were written
by providers (Longo, 2016). Regardless of the clinical guidelines currently in
place, they are guidelines and do not replace provider judgement. A provider’s
lack of faith in their ability to safely prescribe opioids, the inability to detect
abuse or dependence and the ability to have an acceptable discussion regarding
these issues may cloud a provider’s judgement (Longo, 2016). Individuals have a
right to have their pain managed in an appropriate manner which may include the
use of opioids; however, patient rights should be weighed against the danger to
the individual and society (Cheatle, 2015).
Research observed a higher incidence of opiate use long term in patients
that experienced low back pain resulting from injury and those who underwent
spinal surgery (Dowell et al., 2016). Individuals who received more than five
prescriptions for opioids early on for low back pain treatment with up to 140
morphine milligram equivalents (MME) daily had a higher odds ratio for
undesirable effects including misuse, overdose and mortality (Dowell et al.,
2016).
There is no straightforward solution to the epidemic, but research does
show that advocating for use of opioids at the lowest dose for the briefest amount
of time, increasing the educational training on both prescribing and the difference
in tolerance vs dependence, and a better understanding of acute and chronic pain
would aid providers in safer, more successful pain management and reduce the
risk of opioid abuse and diversion (Longo, 2016).
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Financial and Political Implications

A leading cause of outpatient visits and functional impairment among
individuals is unrelenting pain with healthcare cost exceeding $70 billion each
year (Keller et al., 2012). Cost to employers, state and federal family assistance
organizations and attempts to minimize or curtail the use of opiates result in social
issues such as failure to adequately perform job functions at work, school and
home (Dowell et al., 2016). Most guidelines for chronic pain indicate active
physical interventions such as exercise including manual therapy, core
strengthening, coordination and endurance and are evidence-based
recommendations (Azevedo et al., 2015). While detrimental effects of opioid use
have been observed, there is limited evidence related to outcomes using clinical
guidelines (Dowell et al., 2016).
Summary

Opioid use disorders have raised concerns about the relationship of longterm opioid therapy and challenged dangerous patterns and impairment (Dowell et
al, 2016). Providers have expressed unease when it comes to opioid
misappropriation and report an increased anxiety in the treatment of unrelenting
pain with lack of appropriate education in prescribing opiates (Dowell et al.,
2016).
Private and governmental agencies funding the costs of disability and
opiate misuse, abuse, overdose and death would benefit from fiscal prudence.
Providing a survey of provider practices in the four-state area (Kansas, Missouri,
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Oklahoma and Arkansas) would benefit stakeholders understanding of current
health practices for the treatment of chronic pain. This scholarly project aims to
identify what providers prescribe for chronic low back pain and how or if they
utilize any specific deterrents such as UDS and PMDP (NPA, 2012).
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CHAPTER III

Methodology

Research suggests a lack of knowledge and training in various pain
treatment areas and treating non-malignant cancer pain with opioids (Harris et al.,
2008). Nurse Practitioners (NPs) and Physician Assistants (PAs) are asked to
control chronic pain in the primary setting yet meet formidable challenges in how
to select appropriate nonpharmacological and pharmacologic remedies. In
addition, when an opiate is needed these providers are asked to provide continued
monitoring to curtail abuse and diversion (Carter, 2017). The purpose of this
study was to review the prescribing practices of primary care providers in
Southeast Kansas. The data regarding opioid prescription was then compared to
opioid use in other regions of Kansas. This study looked at one specific set of
clinics in Southeast Kansas to discern how providers were treating acute and
chronic pain and if they were following the recommended CDC guidelines when
prescribing opioids.
A major clinical challenge facing the nation is the management of acute and
chronic back pain. The overuse of opioids and the abuse potential associated with
the use of opioids has powered efforts to create a set of guidelines to be used by
clinicians for the treatment and therapy of acute and chronic pain.
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Design

A descriptive retrospective cohort chart review was conducted on thirty
providers from a variety of clinics in Southeast Kansas. The aim of this study was
to discern the quantity of opioid prescriptions written for acute and chronic back
pain in rural Southeast Kansas among multiple clinics. In addition, this project
attempted to discover whether the CDC guidelines had been followed such as the
use of PMDPs and UDS, and appropriate monitoring of the patient was done in
these clinics in Southeast Kansas. The number of opioids prescribed in Southeast
Kansas was then compared to other regions in Kansas.
Sampling

A group of clinics in the Southeast Kansas area were used to obtain this
data on prescribing practices of primary care providers for the treatment of acute
and chronic back pain. These clinics serve patients in the four-state area of
Kansa, Missouri, Oklahoma, and Arkansas (Hudspeth, 2011).
Eight charts from seven clinics with a total of 30 providers, including
physicians, nurse practitioners, and physician assistants were reviewed, across a
variety of specialties within the clinics including internal medicine, family
practice and acute care. Inclusion criteria for this project were individuals with a
diagnosis of acute and/or chronic back pain, adults over the age of eighteen and
individuals that have been prescribed an opioid during their treatment for acute or
chronic back pain. Exclusion criteria for this project consisted of patients under
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the age of eighteen, pediatric providers and individuals that do not have a
diagnosis of acute and or chronic back pain.
Data collection began following approval from the Pittsburg State
University Irene Ransom Bradley School of Nursing Institutional Review Board
and the Pittsburg State University Institutional Review Board. Permission was
also obtained from the board of the clinics to be used. Confidentiality was
maintained by eliminating identifying information regarding patients and
providers.
The benefits of the data collection will be identifying areas for
improvement in the treatment of acute and chronic back pain by the providers in
the clinics studied. The chart review sought to reveal which specialties in the
clinics were utilizing evidence-based guidelines more than the other areas, and
whether different providers (MDs, NPs and PAs) prescribe more opioids than the
others. There was no risk to participation in this project as no identifying
information was used, maintaining confidentiality of both providers and patients.
Instrument

A retrospective chart review was conducted on providers in select clinics
between April 1, 2017 and April 1, 2018. The survey used was created
specifically to gather information of basic provider and patient demographics and
a review of the prescribing practices of the providers. The data regarding opioid
prescribing was compared to regional data to identify how Southeast Kansas
compared to other regions in opioid use. This data was useful in identifying if
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providers were utilizing the CDC’s recommended guidelines when prescribing
opioids for patients with acute or chronic back pain.
Procedure

Demographic information was extracted from each chart to include the
primary care provider’s gender, age, clinical practice (MD, DO, APRN, and PA),
years in practice, DEA licensure and area of practice (Family Practice, Internal
Medicine, or Acute Care). The data collected included the provider’s
participation in pain management courses during their educational training or
continuing education classes since receiving their degree.
Additional data collected from the chart review included what therapies
were initiated for the acute and/or chronic back pain, including nonpharmacological methods. The chart review also noted whether the provider
followed a set of evidence-based guidelines for treating the presenting pain and
subsequent monitoring of the patient, and whether education regarding opiate use
was provided to the patient. Data collection covered a one-year time span from
April 1, 2017 through April 1, 2018.
To extract the data needed for this project, the researcher requested
assistance from the quality improvement manager of the clinics. The quality
improvement manager decoded any identifying information of both providers and
patients prior to providing the extracted data to the researcher, thus ensuring
confidentiality.
SPSS software was used to compile the information and trends were noted
in the number of providers that used a set of guidelines, what those guidelines
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were, the use of a contract between the patient and the provider, how they
monitored the patient for compliance and abuse potential, length of time the
patient was provided opioids and what opioids were prescribed. Southeast Kansas
was then compared to other regions in Kansas regarding the number of opioids
individuals are receiving.
Analysis

Following approval from the Pittsburg State University Irene Ransom
Bradley School of Nursing Institutional Review Board, the Pittsburg State
University Institutional Review Board and board approval for the clinics, data
collection took place over four weeks or until all data had been obtained and the
data collected was from a one-year time frame. Confidentiality was maintained by
not using any identifying information regarding patients or providers, and all
information obtained was securely locked in a cabinet within the researcher’s home.
Once all the information had been extracted, the data was analyzed using SPSS
software to answer the questions set forth in Chapter I:
1) Are clinicians in selected clinics in rural Southeast Kansas prescribing
opioids using the current CDC recommendations and guidelines?
2) How does Southeast Kansas compare to other regions in Kansas regarding
the number of opioids written by providers?
Assumptions

The assumptions with this study were that provider documentation was
complete and accurate, a clear set of guidelines were used and appropriate
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monitoring of the patients for abuse risk and accurate documentation of
alternative modalities used. It was also assumed that anonymity was maintained
throughout the collection process. An added conjecture was that the information
extracted was an appropriate representation of provider practices in the four-state
area (Kansas, Missouri, Oklahoma, and Arkansas) and the surrounding counties.
Limitations

One limitation of this study was the limited number of clinics that was
utilized may not provide a complete representation of all clinics in the area. An
additional limitation is the short time frame that was used for data collection and
the small representative sample of providers. This research may leave the results
open to inspection regarding provider judgement in therapeutic modality choice
when it comes to acute and chronic back pain. Updated treatment modalities
chosen by providers and updated guidelines that providers are referencing may
not be adequately identified in this study due to the evolving nature of medicine.
As this was a chart review, there was no bias in self reporting of therapies chosen
for the treatment of both acute and chronic back pain. The intent of this research
was to identify how providers chose to treat acute and chronic back pain, whether
they were utilizing a standard set of guidelines, how they monitored the patients
and whether they were inadvertently contributing to the opioid epidemic.
Delimitations

Provider differences in the treatment of pain and ongoing pain
management which includes non-prescription pain medications and opioids may
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be a delimitation in this research. A chart review would be unable to establish the
reason for a provider’s clinical judgement when choosing a course of treatment,
but it would identify if providers are following recommended CDC guidelines in
their practice.
Summary

This research will help identify the current practices of local healthcare
providers when treating acute and/or chronic back pain. It will note whether
providers are doing due justice and following the CDC’s recommended guidelines
when providing opioids for pain management, in addition to utilizing tools to
mitigate abuse potential, and identify individuals at risk for opiate abuse. This
research also aimed to recognize whether providers used nonpharmacological
therapies as first line treatment for chronic and acute back pain.
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CHAPTER IV

Evaluation Results

More than 20 million American adults suffer from pain, and
approximately 23 million more suffer from chronic relentless pain leading to
disability, loss of work productivity, diminished quality of life and diminished
health status (Meldrum, 2016). The economic burden of this is more than $500
billion annually, not including pain in children, individuals residing in long-term
care facilities, military persons and prisoners (Pizzo, 2012). The cost for pain in
the U.S. related to lost wages and medical care exceed the cost for cancer, heart
disease and diabetes collectively (Pizzo, 2012).
An integrative approach with physical therapy, psychological, mental and
physiological therapy, relaxation, coping methods and self-hypnosis are the bestknown alternatives to opioids (Meldrum, 2016). Educating clients on adaptive
habits to manage incapacitating consequences of their ailment is critical for
efficacious management of pain (Peters, 2017). Individuals need to learn coping
mechanisms to manage taxing life events without the use of drugs and education
is paramount.
The year 2016 brought a request for change by The Physicians for
Responsible Opioid Prescribing, leading multiple health care organizations to
41

implore upon the Joint Commission for Accreditation of Health Care
Organizations, to stop the compulsory pain assessment implying that it promotes
hazardous pain control practicing (Meldrum, 2016). While this request did bring
about some changes in prescribing practices for nonacute, nonterminal pain, it has
also sparked new debates regarding pain management. The initial campaign from
pharmaceutical companies that opioids were safe and not addictive was no longer
found to be true. Pharmaceutical manufacturers adept at targeting markets of
individuals, benefits to insurance carriers and creative free enterprise among drug
traffickers brought proof that opioid use and accessibility often led to lethal
consequences (Meldrum, 2016).
The United States continues to see an increase in the opioid epidemic, and
intricate tactics will be needed to pursue developing perils and respond
appropriately. More than 200 million opioid prescriptions were distributed from
retail U.S. pharmacies in 2016 (Throckmorton, 2018). Preventing new addiction
through educational improvements regarding opioid prescribing and promoting
the use of non-opioid pain medications are just a couple of ways to tackle the
destructive influence of the opioid epidemic.
As chronic pain is so pervasive it is unrealistic and unfavorable to expect
pain specialists to manage all pain for patients with less than 4000 specialists in
the country (Pizzo, 2012). It is also unreasonable to expect primary care
providers to manage pain without the appropriate education.
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Purpose of the Study

The purpose of this scholarly project was to discern the quantity of opioid
prescriptions written for acute and chronic back pain in rural Southeast Kansas
among multiple clinics. In addition, this project would discover whether CDC
guidelines had been followed such as the use of UDS and PMDP, and appropriate
monitoring of the patient in these clinics in Southeast Kansas. This project noted
if clinicians attempted nonpharmacological and nonopioid therapy to manage
acute and chronic back pain before they initiated opioid therapy. These numbers
would be compared to other regions in the state of Kansas to determine how
Southeast Kansas is contributing to or changing the opioid crisis.
Research Questions

The research questions for this scholarly project were:
1) Are clinicians in selected clinics in rural Southeast Kansas prescribing
opioids using the current CDC recommendations and guidelines?
2) How does Southeast Kansas compare to other regions in Kansas regarding
the number of opioids written by providers?
Study Results

This was a retrospective chart review on seven small rural Southeast
Kansas clinics. A total of eight charts among 30 providers in the clinic were
reviewed totaling 240 chart reviews, and basic provider demographics were
obtained. Provider demographics included: provider degree (MD, DO, NP, PA),
provider age, provider gender, years in practice, current DEA licensure, practice
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specialty, and if the provider had specific pain management education with their
formal training or if they had participated in any continuing education courses
related specifically to pain management. Please refer to Tables 2-7, and
Histogram 1 and 2.
Provider Demographics

Table 2. Clinic Location
Pittsburg

Frequency
104

Percent
43.3

24
8
40
16
24
24
240

10.0
3.3
16.7
6.7
10.0
10.0
100.0

Parsons
Independence
Iola
Columbus
Coffeyville
Baxter Springs
Total

Table 1 shows the number of charts provided from each clinic for review. Over 43.3% of
all charts came from a clinic in Pittsburg.
(240= the number of charts reviewed in total- 8 charts per provider)
Table 3. Provider
Frequency
Medical Doctor
Doctor of Osteopathic Medicine
Nurse Practitioner
Physician Assistant
Total

80
8

Percent
33.3
3.3

128
24
240

53.3
10.0
100.0

Table 2 shows that more than 50% of the providers were Nurse Practitioners followed by
just over 30% that were Medical Doctors.
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Histogram 1

The average age of the providers was 48.5 years (SD = 15.17). The histogram indicates a
larger proportion of providers that were 40 years or less.
Table 4. Provider Gender
Frequency
Valid

Male
Female
Total

Table 3 indicates that less than 75% of the providers were female

45

64

Percent
26.7

176
240

73.3
100.0

Histogram 2

The average number of years the provider has been in practice was 12.3 years (SD=
14.032). The histogram indicates that more providers have been in practice less than
fifteen years.
Table 5. DEA Licensure Current
Frequency
Yes

240

All (100%) of the providers have a current DEA License.
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Percent
100.0

Table 6. Provider Specialty
Frequency
Internal Medicine
Family Practice
Acute Care
Total

40
168
32
240

Percent
16.7
70.0
13.3
100.0

Table 5 indicates that less than 75% of the providers practice in Family Medicine and less
than 20% practice in Internal Medicine.

Table 7. Pain Management Education in Training
Frequency
Yes
No
Total

8
56
64
176
240

Missing
Total

Note: Missing values were due to providers that did not provide a response to the
question.
Table 6 indicates that slightly less than one quarter (23.3%) of providers did not get
formal pain management education during their training.
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Percent
3.3
23.3
26.7
73.3
100.0

Table 8. Continuing Education in Pain Management
Frequency
Yes
No
Total

48
16
64
176
240

Missing
Total

Percent
20.0
6.7
26.7
73.3
100.0

Note: Missing values were due to providers not giving a response to the question.
Of the providers that did answer the question, one-fifth (20%) of them have taken some
continuing education course in pain management since beginning practice.
Patient Demographics

Basic demographic information from each patient chart that was also
obtained and reviewed. To be included in the study; each chart had to have a
diagnosis of acute or chronic back pain. Patient information obtained included
patient age, patient gender, patient ethnicity and whether they were insured,
uninsured or underinsured. During the chart review, it was found several times
that although the patient may have come in to be seen for an acute or chronic back
pain, the diagnosis given was “other chronic pain”. Please refer to tables 9-11 and
Histogram 3.
Table 9. Diagnosis of Acute or Chronic Pain?
Frequency
Valid

Yes

Percent

240

100% of the charts reviewed had a diagnosis of acute or chronic back pain which was
criteria for the inclusion into the study.

48

100.0

Histogram 3

The average age of the patient was 48.07 years (SD=13.916). The largest grouping of
individuals tended to be in the range of 50-60 years of age.
Table 10. Patient Gender
Frequency
Male

110

Percent
45.8

Female
Total

130
240

54.2
100.0

More than one-half of the patients (54.2%) receiving opioids were women
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Table 11. Patient Ethnicity
Frequency
Caucasian
Hispanic
African American
Native American
Caucasian/Hispanic
Total

193
8
10
10
2
223
17
240

Missing
Total

Percent
80.4
3.3
4.2
4.2
.8
92.9
7.1
100.0

Note: Missing values were due to patients that did not answer the question regarding
ethnicity.
More than three-fourths of the patients identified themselves as Caucasian, followed by
4.2% identifying as African American or Native American, 3.3% identifying as Hispanic
and 0.8% identifying as both Caucasian and Hispanic.
Table 12. Insurance
Frequency
Insured
Uninsured
Total

169
71
240
240

Total

Percent
70.4
29.6
100.0
100.0

Close to three-fourths (70.4%) of the patients did have some type of insurance.

Research Questions

1) Are clinicians in selected clinics in rural Southeast Kansas prescribing
opioids using the current CDC recommendations and guidelines?
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2) How do the statistics pertaining to opioid use for treating acute and
chronic back pain in the selected clinics compare to other regions in the
state of Kansas?
Please refer to Tables 13-20 for data related to practice question one.
Table 13. Were CDC Guidelines Followed?
Frequency
Yes
No
Total

Percent

188
52
240

78.3
21.7
100.0

More than three-fourths (78.3%) of the providers were following CDC guidelines.
Table 14. Did Provider Start with Conservative Management: Ice/Heat/
Ibuprofen/Tylenol/Steroids-Physical Therapy or a combination of
conservative treatment?
Frequency
Yes
No
Total

Percent

197
43
240

More than three-fourths (82.1%) of the providers began with conservative management
for acute or chronic back pain.
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82.1
17.9
100.0

Table 15. Was education provided to the patient regarding opioid use?
Frequency
Yes
No
Total

Percent

33
81
114
126
240

Missing
Total

13.8
33.8
47.5
52.5
100.0

Note: Missing value were because the provider was following guidelines and did not
prescribe opioids.
A little more than one-tenth (13.8%) of providers prescribing opioids provided education
to the patient, with one-third (33.8%) of the providers not providing patient education
regarding the use of opioids.
Table 16. If an Opioid was prescribed by the Provider- was it before or after conservative
therapy?
Frequency
Before
After
None Prescribed
Total

Percent

56
56
128
240

There was an equal split with just less than one fourth of providers prescribing opioids
(23.3%) before conservative management and just less than one fourth (23.3%)
prescribing opioids after conservative management, while slightly more than one-half
(53.3%) of providers not prescribing opioids at all.
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23.3
23.3
53.3
100.0

Table 17. Once the opioid was prescribed: Did provider obtain a Controlled
Substance Agreement?
Frequency
Yes
No
Total

Percent
69
44
113
127
240

Missing
Total

28.7
18.3
47.1
52.9
100.0

Note: Missing values were because the Provider did not prescribe opioids.
Of the providers that chose to prescribe opioids, more than one-fourth (28.7%)
providers obtained a Controlled Substance Agreement.
Table 18. Did provider consult a Prescription Drug Monitoring Program?
Frequency
Yes
No
Total

Percent

46
67
113
127
240

Missing
Total

Note: Missing values were due to providers not prescribing opioids for acute/chronic
back pain.
Of the providers that chose to prescribe an opioid, more than one-fourth (27.9%) did not
consult the Prescription Drug Monitoring Program prior to prescribing the opioid, with
less than one-fifth (19.2%) consulting the Prescription Drug Monitoring Program prior to
prescribing an opioid.
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19.2
27.9
47.1
52.9
100.0

Table 19. Did the provider obtain a urine drug screen?
Frequency
Yes
No
Total

71
42
113
127
240

Missing
Total

Percent
29.6
17.5
47.1
52.9
100.0

Note: Missing values were due to providers not prescribing opioids.
Of the providers that did prescribe opioids, more than one-fourth (29.6%) of them
obtained a urine drug screen, while less than one-fifth (17.5%) of providers did
not obtain a urine drug screen.
Table 20. What opioid was prescribed?
Frequency
Valid

Hydrocodone/Oxycodone
Fentanyl
Morphine
Both Hydrocodone and Morphine
Fentanyl and Morphine
Total

Missing
Total

99
2
5

Percent
41.3
.8
2.1

5
1
112
128
240

2.1
.4
46.7
53.3
100.0

Note: Missing values were due to providers not prescribing opioids
More than one-half (53.3%) were missing which means that the prescriber did not
prescribe opioids. Of the opioids prescribed, less than one-half (41.3%) of the opioids
given were hydrocodone or oxycodone.
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Table 21. Dose of Opioid
Frequency
Hydrocodone/Oxycodone 5/10 mg
Morphine
5/10/15/30mg
Morphine/Hydrocodone/Oxycodone 5 and 5
Fentanyl/Morphine
50 and 30
Total
Missing
Total

99
5
5
1
110
130
240

Percent
41.3
2.1
2.1
.4
45.8
54.2
100.0

Note: Missing values were due to providers not prescribing opioids
More than one-half (54.2%) were missing meaning they did not prescribe opioids. Of the
providers that did prescribe an opioid, less than one-half (41.3%) were given either 5 or 10
mg as an initial dose of hydrocodone or oxycodone, followed by 2.1% being prescribed a
dose of morphine and 2.1% being provided both hydrocodone or oxycodone and morphine.
Specific Purpose of the Study

The goal of this scholarly project was to discern the quantity of opioid
prescriptions written for acute and chronic back pain in rural Southeast Kansas
among multiple clinics. In addition, this project attempted to discover whether
CDC guidelines had been followed such as the use of UDS and PMDP, and
appropriate monitoring of the patient was done in these clinics in Southeast
Kansas. This project also noted if clinicians attempted nonpharmacological and
nonopioid therapy to manage acute and chronic back pain before they initiated
opioid therapy. These numbers were compared to other regions in Kansas to
determine how Southeast Kansas is contributing to or changing the opioid crisis.
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Study Findings

It is no secret that the United States (US) has had a problem with abuse,
misuse and diversion of opioids for several years. This issue has been found to be
multi-factorial, and includes improper prescribing, an assortment of drug
suppliers both legal and illegal, delayed government reaction and incessant
advertising for off-label consumption by pharmaceutical companies (Maxwell,
2010).
A retrospective chart review was performed to see if providers in several
rural Southeast Kansas clinics may be contributing to the misuse, abuse and
diversion of opioids due to inappropriate prescribing practices outside of
recommended CDC clinical guidelines. The information obtained would then be
compared with other regions in the state of Kansas.
The survey used was created specifically to gather information of basic
provider and patient demographics and a review of the prescribing practices of the
providers. The specific questions addressed was related to the recommended
CDC clinical guidelines for prescribing opioids being followed within the rural
Southeast Kansas clinic. The recommended guidelines being reviewed were 1)
conservative management of acute or chronic low back pain with non-steroidal
anti-inflammatory drugs (NSAIDS), acetaminophen, physical therapy, or use of
ice or heat packs? 2) if an opioid was prescribed, did the provider consult the
prescription drug monitoring system, obtain a controlled substance agreement
with the patient, or obtain a urine drug screen prior to beginning opioid therapy?
3) did the provider begin with the lowest possible dose of opioid therapy, what
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opioid was given and at what dose? 4) did the provider educate the client on the
use of opioid therapy? 5) has the provider received specific training in pain
management through formal education or taken continuing education courses
specifically geared toward pain management?
Provider Demographics Discussion

There were seven clinics used for this study in the Southeast Kansas
region. The clinic in Pittsburg had 43.3% of the practicing providers, Iola had
16.7% of the providers, the Parsons clinic had 10% of the providers, Coffeyville
and Baxter Springs had 10% of the practicing providers, and Independence had
3.3% of the providers.
The providers were broken down based on degree; 33.3% were medical
doctors, 3.3% were Doctor of Osteopathic Medicine, 53.3% were nurse
practitioners and 10% were physicians’ assistants. The average age of the
provider was 48.5 years with a standard deviation of 15.17. There were 26.7%
male providers and 73.3% female providers and the average number of years in
practice was 12.3 years with a standard deviation of 14.032. All the providers
held a current DEA licensure. Provider specialties were broken down into
internal medicine with 16.7% of practicing providers, 70% of the providers
practiced in Family Medicine and 13.3% practiced in Acute Care.
Just over 73% of providers did not answer whether they had received any
formal training in pain management, 3.3% replied that they had received formal
training and 23.3% reported not receiving any formal pain management
education. A significant number of providers (73.3%) did not answer if they had
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attended any continuing education courses specifically geared towards pain
management, 20% replied that they had attended continuing education courses for
pain management and 6.7% had not taken any continuing education courses.
Patient Demographics Discussion

Patient demographic information was also obtained from each patient
chart. All charts reviewed had a diagnosis of acute or chronic back pain listed in
the chart. The average age of the patient was 48.07 years with a standard
deviation of 13.916. The largest age group of the patients was between the ages
of 50-60 years. Males represented 45.8% of the patients and female comprised
54.2% of the charts reviewed.
Of the charts reviewed, 80.4% of the patients identified themselves as
Caucasian, 3.3% identified as Hispanic, 4.2% identified as African American,
4.2% identified themselves as Native American and 0.8% identified themselves as
Caucasian/Hispanic. Insured patients comprised 70.4% of the patients while
29.6% of the patients were uninsured.
Analysis of Research Questions

The results of the survey revealed that 78.3% of the providers practicing in
the clinics were following the recommended CDC guidelines for opioid
prescribing while 21.7% of the providers were not following the guidelines.
Conservative management which included the use of NSAIDs, acetaminophen,
ice, heat, physical therapy or a combination of all was used by 82.1% of the
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providers chose to use conservative management and 17.9% did not start
treatment with conservative therapies.
Patient education regarding the use of opioid therapy revealed that 13.8%
of the providers educated the patient on opioid use and 33.8% did not provide the
patient with any education regarding opioid therapy and the 52.5% that did not
provide education was the result of following CDC guidelines and no opioids
were being prescribed to the patient. When looking at whether an opioid was
prescribed before or after conservative management, 53.3% did not receive any
opioids, 23.3% of patients received an opioid prior to conservative management
and 23.3% received an opioid after conservative management was tried.
CDC recommendations include the use of a controlled substance
agreement (CSA) and while 52.9% of the providers did not use a CSA because no
opioids were prescribed, 28.7% did utilize a CSA prior to prescribing opioids and
18.3% did not obtain a CSA prior to initiating opioids. The use of prescription
drug monitoring programs (PDMP) are also recommended and 52.9% of the
providers did not consult the PDMP because they did not prescribe an opioid,
27.9% did not consult the PDMP prior to initiating an opioid and 19.2% of the
providers did utilize the PDMP. Urine drug screening (UDS) is another
recommendation when prescribing opioid therapy and while 52.9% of the
providers did not obtain a UDS because they did not prescribe opioids, 29.6% of
the providers did obtain a UDS and 17.5% did not obtain a UDS.
Hydrocodone or oxycodone were utilized for pain management within the
clinics was in 41.3% of patients received either hydrocodone or oxycodone, 0.8%
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were provided fentanyl, 2.1% were given morphine, 2.1% were given both
hydrocodone and morphine, 0.4% were provided fentanyl and morphine and
53.3% did not receive any opioids. CDC guidelines recommend using the lowest
effective dose if pain is going to be managed with an opioid. An initial dose
hydrocodone 5 mg or oxycodone 10 mg was given to 41.3% of patients, 2.1%
received a dose of 5/10/15 or 30 mg of morphine for an initial dose, 2.1%
received 5 mg of morphine and 5 mg of either hydrocodone or oxycodone as an
initial dose, 0.4% received 50 mcg of fentanyl and 30 mg of morphine as an initial
dose while 54.2% did not receive any opioid therapy.
Regional Data

Regional data was retrieved from the Kansas Epidemiological Data
Dashboard and it was broken down into counties
(http://www.preventoverdoseks.org/kpdo_data.htm). The researcher took the data
from each county in each region of Kansas and compiled the data to reflect the
region. The most recent data available was from 2017 and the information looks
at each region of Kansas but does not reflect any one clinic or set of clinics in the
other regions.
The information for each region is the number of opioids per 100 persons
in the region. The Kansas City Metro region had the lowest number of opioids at
96.13 opioids per 100 persons. The Southwest region came in with the next
lowest at 110.2 opioids per 100 persons. The Northeast region in Kansas held the
third lowest number of opioids with 112.605 opioids per 100 persons. The
Northwest region of Kansas revealed 116.45 opioids per 100 persons. The North
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Central region had 124.03 opioid per 100 persons while the South-Central region
has 136.73 opioids per 100 persons. The Southeast Kansas region overall had the
highest number of opioids with 157.858 opioids per 100 persons. This data
clearly identifies that Southeast Kansas has the largest number of opioids per 100
residents than the other regions in the state of Kansas, however, in the clinic that
this researcher looked at, just over one half of the providers in the clinics did not
prescribe opioids for acute or chronic back pain.
Summary

The purpose of this study was to see if providers within a set of clinics in
the Southeast Kansas area were contributing to the opioid problem in the US with
inappropriate prescribing practices compared to other regions in Kansas. The data
clearly indicates that Southeast Kansas has the highest number of opioids per 100
persons compared to other regions in the state, however, this researcher was only
able to gather data from one set of clinics in the Southeast Kansas region, and the
information revealed that more than half of the providers did not prescribe an
opioid to patients for management of acute or chronic back pain. The data
obtained unfortunately does not provide information regarding various clinics
across the other regions of Kansas. Within the clinics that were researched, just
over 50% of the providers followed CDC guidelines for the safe prescribing of
opioids while just over 25% of the providers obtained a CSA and obtained a UDS.
Just over one-fourth did not consult the PDMP prior to initiating opioid therapy.
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CHAPTER V

Discussion of Findings, Recommendations and Conclusions

The purpose of this scholarly project was to determine if a set of clinics in
Southeast Kansas may be contributing to the opioid epidemic and then compare
Southeast Kansas’ opioid use to other regions in Kansas. The data retrieved from
the clinics in Southeast Kansas looked to see if providers within the clinic were
following CDC guidelines when prescribing opioids for acute or chronic low back
pain.
Chronic pain management can be challenging for providers that have
specialized in pain therapy, much less for providers that lack formal education.
Opioids should not be the initial medication provided to patients with chronic
pain. Different types of pain are treated with various medications and are often
treated more effectively with non-opioid pharmacological therapy. Treatment of
pain is not a one drug fits all category and each patient should be evaluated
independently regarding the type of pain they have and ascertain the best
approach to treatment that carries the least amount of side effects for the patient.
Roughly 25 million adult Americans experience pain every day and about
23 million more endure relentless pain causing debilitation, loss of job
productivity, and a diminished quality of life (Meldrum, 2016). Opioid addiction
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is a societal issue and the misuse of drugs is among the 25 leading causes of the
death in the world (Beneitez, 2017).
The best approach to chronic pain including both acute and chronic low
back pain is a multidisciplinary method encompassing psychological, physical,
cognitive-behavioral therapies that focus on respite and coping mechanisms with
self-hypnosis (Meldrum, 2016). Managing chronic noncancer pain in individuals
with substance abuse disorders can be slightly more challenging for providers, but
following recommended guidelines, professionals can carefully and successfully
treat these persons for their pain and their addiction.
Research Questions and Relationship of Outcomes to Research

The CDC recommended guidelines include the use of nonpharmacological
and nonopioid therapy as first-line treatment to include ibuprofen, Tylenol, ice,
heat , physical therapy or a combination of each, education provided to patients
regarding goal expectation and opioid use-risks versus benefit, if an opioid was
prescribed, was it before or after conservative management, the choice of the
opioid and dose provided, use of a controlled substance agreement, use of
prescription drug monitoring programs (PMDP); and periodic drug screenings to
verify compliance and deter abuse and misuse.
Demographic information obtained on the providers in this study revealed
that the average age of the provider was 48.5 years, with 73.3% of the providers
being female compared to 26.7% male providers and the average years in practice
was 12.3 years. The age of the provider is consistent with other research
conducted showing an average provider age of 49.1 (Keller, 2012). Inconsistent
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with other research is the provider gender, which is the opposite from Keller’s
(2012) study where 71% of providers were male. The average number of years in
practice of this study (12.3 years) was slightly lower than Keller’s (2012) study
which had an average of 18.5 years in practice.
Patient demographics was also looked it and this study showed the
average age of the patient receiving opioid therapy was 48.07 years. The largest
grouping of individuals ranged between 25-70 years of age (Keller, 2012). This is
consistent with other research conducted showing the average age of patient
receiving opioid therapy between the ages of 19-40 at 20.4%, 28.3% of
individuals between the ages of 41-65 years of age, and 35.3% of individuals
receiving opioid therapy over the age of 65 (Keller, 2016). The most recent data
reviewed by the CDC indicates that the largest group of individuals receiving
opioid therapy between the ages of 25-40 years of age (CDC, 2017).
Patient gender in this study indicated that 54.2% of females received
opioids which was consistent with 61.2% females found in the study done by
Keller (2012). This was inconsistent with the most recent data from the CDC
revealing that 55.6% of males received opioids compared to 44.4% of females.
Patient ethnicity was also gathered in this study and revealed that 80.4%
of patients receiving opioids were Caucasian, followed by 4.2% African
American, 4.2% Native American and 3.3% Hispanic with 0.8% identifying as
Caucasian/Hispanic. This was partially consistent with other research that
indicated 59.9% of opioid recipients were Caucasian, 27.4% African American,
8.1% Hispanic, 0.8% Native American and 3.4% identifying as other (Keller,
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2012). This study was also somewhat consistent with the most recent CDC data
which revealed 8,128 Caucasian individuals receiving opioids, 1,400 African
Americans and 2,156 Hispanics receiving opioids (CDC, 2017).
This study also revealed that of the individuals receiving opioid therapy,
70.4% held some form of insurance compared to 29.6% that were uninsured. This
data was consistent with other research revealing that more than three-fourths of
individuals receiving opioids held some type of insurance and only 4.6% of
persons being uninsured (Keller, 2012). Data retrieved from the CDC broke this
information down into an estimation of the percentage of persons that had a drug
related hospitalization or emergency room visit based off insurance and showed
that 84.3% of individuals that were hospitalized with a drug related event or
visited the emergency room due to a drug related event held some form of
insurance (CDC, 2017).
The results of this study were consistent with prior studies indicating that
pain management is primarily provided by family practice providers followed by
internal medicines providers. Nurse practitioners and physician assistants
prescribe more opioids than pain management specialists (Kaye, 2017). Seventy
percent of the providers in this study were family practice, and 16.7% were
internal medicine. Of the 70% of family practice providers, 53.3% were nurse
practitioners followed by 33.3% of medical physicians.
Considering formal pain management education during training, the
results of this survey are consistent with prior research. The survey revealed that
23.3% of providers did not receive any pain management training during their
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formal education while 3.3% report receiving formal education with pain
management. In one research study completed in 2009 in which more than 30
physician organizations, revealed that education for pain management was
inadequate and did not lead to proficiency (Pizzo, 2012). While not required and
not a formal form of education, the results of this study did reveal that of the
providers that answered the question, 20% reported that they had taken some
continuing education classes specifically geared toward pain management
compared to 6.7% that had not taken any classes, however 26.7% chose not to
answer the question.
There are a finite number of pain specialists available making primary
care providers ideally responsible for providing pain management to patients.
However, if education and training is not restructured, effective pain management
will continue to be a challenge. Providing education for primary care providers
can increase patient outcomes through a more comprehensive understanding of
pain, prevention and treatment of pain with further knowledge on avoiding abuse
and misuse of medication.
Conservative management of acute and chronic low back pain has been
shown to be more effective than opioids, and studies have revealed that nonsteroidal anti-inflammatory drugs (NSAIDS) acetaminophen and aspirin are
frequently provided (Chou, 2007). The results of this study revealed that 82.1%
of providers in the clinic, initiated treatment with an NSAID, sometimes coupled
with physical therapy, ice or heat treatment. This follows the CDC recommended
guidelines for the use of conservative management for low back pain either acute
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or chronic. This study also revealed that 53.3% of clinic providers followed the
recommended guidelines and did not prescribe opioids to their patients, yet 23.3%
of the providers prescribed opioids prior to the use of conservative management;
and 23.3% prescribed opioids after trialing conservative management.
When prescribing opioids, the lowest effective dose for the shortest
amount of time should be prescribed if the provider is following the
recommended CDC guidelines. This study revealed that 53.3% of providers
followed guidelines by not prescribing opioids, and although it is recommended
that providers begin opioid dosing with the lowest dose, this study found that
hydrocodone was initiated at the lowest dose of 5/325 mg, oxycodone was
initiated at the higher dose of 10/325 mg. Morphine alone or a combination of
morphine and either hydrocodone or oxycodone were the next most frequent
initial prescriptions. Morphine alone was given at a dose of 5mg or 30 mg as the
most prescribed initial dose while the combination of morphine and hydrocodone
of oxycodone dose was 5mg and 5 mg combined. The lease prescribed initial
treatment was a combination of fentanyl and morphine at 0.4% with an initial
dose of 50mcg and 30 mg respectively.
CDC guidelines also recommend that providers consult the prescription
drug monitoring program (PDMP), obtain a urine drug screen (UDS) and a
controlled substance agreement (CSA) if opioid therapy is initiated. Though
52.9% of providers did not prescribe opioids, 27.9% of providers that did
prescribe opioids did not consult a PDMP first. Continuing with CDC
recommendations, 29.6% of providers did obtain a UDS prior to opioid
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prescribing while 17.5% did not obtain a UDS prior to prescribing an opioid.
Lastly, still following CDC guidelines, of the providers that wrote a prescription
for an opioid, 28.7% of providers obtained a CSA prior to the prescription while
18.3% did not obtain a CSA when prescribing an opioid.
A key benefit to improving the outcome of a patient suffering from
chronic pain is education that incorporates the individual’s thoughts regarding
pain, their expectation for pain control and any concerns they have. Of the
providers that did prescribe an opioid, 33.8% of providers did not educate their
patient regarding opioid therapy and the dangers of opioid therapy while 13.8% of
the providers did provide the patient with education.
The clinics used in this study revealed that more than one-half of the
providers were consistently following the recommended CDC guidelines,
however, regional data showed that Southeast Kansas has the highest number of
opioids per 100 residents at 157.858 opioids per 100 residents. Comparing other
regions in Kansas to the Southeast Kansas region, Southeast Kansas has a long
way to go to help curb the opioid epidemic compared to other regions in Kansas.
The Kansas City Metro region and the Southwest region held the lowest rate of
opioids per 100 residents. The regional data was retrieved from the Kansas
Epidemiological Data Dashboard and held the most recent data from 2017
(http://www.preventoverdoseks.org/kpdo_data.htm).
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Educational Policy Implications

This study reveals that pain management is challenging even for providers
that specialize in pain, more so for providers in family practice or internal
medicine that receive little formal education in pain management. Health
outcomes for patients would benefit immensely from educated providers
regarding pain and the most effective treatment available. Better provider
education would not only improve outcomes but would reduce costs associated
with drug related overdose and emergency room visits, patient abuse, diversion of
opioids and patient satisfaction as well.
Policy Implications

The tendency for providers to overprescribe or under-prescribe medication
for pain leaves providers in a quandary. With reimbursement tied to patient
satisfaction, not treating a patient’s pain results in a poor satisfaction score for
providers, yet over-prescribing for pain leads them to open to litigation even
under the best of intentions, simply due to lack of formal education.
Research clearly shows that treatment with NSAIDs, acetaminophen, ice,
heat, and physical therapy are superior to treatment with opioids for acute and
chronic back pain, and insurance companies should recognize this benefit and be
supportive of conservative management in patients. A reduction in opioid use not
only improves patient outcomes, but reduces the annual cost associated with
opioid dependence and its sequelae.
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Theoretical Model

Two theoretical models were used for this study and included Patricia
Benner’s theoretical model, From Novice to Expert (1984) and Nola Pender’s
(1982) Health Promotion Model. With Patricia Benner’s theoretical manner, the
new provider grows in practice through exploration, repetition and employment of
evidence-based skills, the provider progresses from conceptual principles to
perception and proficiency. Applying and developing knowledge are the result of
practice that links theory to research (Moran, 2017). Utilizing knowledge,
experience and evidence-based practice allows the clinician to improve the care
provided to patients.
Nola J. Pender’s Health Promotion Model is applicable when considering
how an individual’s surroundings and upbringing can influence the decisions that
persons makes, how individuals achieve their dreams, and the obstacles that either
hinder or entice them. Providers are role models to other people and promote
healthy behaviors through education. If health disparities increase the likelihood
that an individual will become addicted to prescription pain medication, then
providers need to be more cognizant of how they prescribe and become better
stewards of the community with an emphasis on health promotion. Promotion of
health through education within the community will allow the provider crucial
experiences in knowledge but offers the opportunity for them to be role models
and improve the life of others before chronic illness and poor lifestyle choices
take over.
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Relationship Outcomes

Knowledge of the pathophysiology of pain can guide the provider into an
appropriate diagnosis for the patient. However, due to the chronic and often
coinciding factors, the diagnostic work-up can be challenging for even the more
experienced clinician. The clinician cannot just simply perform a quick
assessment and come to a diagnosis it often requires detailed history and a
thorough physical exam and imaging to be done. An effective history and
physical exam for a pain visit can often take more time than the allotted 20
minutes allowed for each visit. The use of validated tools to assess pain should be
used at each visit (Leonardi, 2015).
While diagnosing a patient’s pain can be challenging, coming up with an
appropriate treatment plan can be equally as trying. The history of the pain, prior
treatments, detailed medical history, the age of the client, the gender, social,
cultural and psychological factors all need to be carefully considered. A detailed
conversation regarding the patient’s expectation for pain management should be
reviewed, and the care should be focused on the patient.
Research has clearly shown that for acute and chronic pain, multiple
nonpharmacological and non-opioid pharmacologic treatments were most
effective especially if coupled with exercise therapy. A multi modal treatment
plan ideally will allow the individual to function better enabling them to lead a
healthier lifestyle which in turn improves one’s quality of life.
The goal in performing a retrospective chart review of providers practices
in a rural Southeast Kansas community clinic setting was to identify if providers
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may be contributing to the opioid epidemic through failure to follow CDC
recommendations. The CDC guidelines are intended to keep patients safe while
guiding clinicians in how to prescribe opioids if necessary. Research clearly
indicates that more than 50% of controlled substances are prescribed by primary
care providers which is consistent with the results of this study revealing 70% of
providers practiced in family medicine (Carter, 2017).
Provider demographics in this study showed the average age of the
provider to be 48.5 years, a higher percent of female providers at 73.3% and the
average years in practice at 12.3 years. The average age of the provider is 49.1
years (Keller, 2012). This research revealed a higher number of female providers
with fewer years in practice at 12.3 years compared to prior research showing
71% of providers as male and an average of 18.5 years in practice (Keller, 2012).
Patient demographics for this research revealed the average age of the
patient receiving opioids to be 48.07 years which is comparable to previous
research showing 20.4% of patients between the ages of 19-40 years, 28.3% of
patients between 41-65 years and 35.3% of patients over the age of 65 receiving
opioids (Keller, 2012). This study revealed more females (61.2%) receiving
opioid therapy compared to prior research 54.2% (Keller, 2012). Ethnicity of the
patient showed 80.4% of patients receiving opioids identifying as Caucasian
compared 59.9% with Keller’s (2012). Demographic location could account for
this difference between these numbers. Individuals with insurance also held a
higher incidence of opioid use in this study with 70.4% having some form of
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insurance which is consistent with prior studies showing that only 4.6% of
individuals were uninsured (Keller, 2012).
Providers prescribing medications for chronic pain should feel
comfortable and have adequate training in the pathophysiology of pain and the
appropriate therapy to treat specific types of pain. Research shows that primary
care providers do not feel as though they received sufficient education regarding
pain management and are not certain of their competence when prescribing pain
medications (Keller, 2012). This study shows that of the providers that answered
the question about receiving education in pain management less than one quarter
(23.3%) reported that they did not receive formal education and, only 3.3% did
receive education in pain management.
The CDC recommended guidelines clearly indicate that nonpharmacological, non-opioid therapy should be initiated prior to initiating
treatment with opioids; however, once the decision to prescribe opioids has been
made, the clinician is best served by obtaining a urine drug screen, consulting
with a prescription drug monitoring system, having a frank conversation
regarding the potential harm of opioid therapy with the patient and obtaining a
controlled substance agreement with the patient (Dowell, 2016). This study
reveals that 78.3% of providers did follow CDC guidelines and did not prescribe
opioid therapy. Of the clinicians that saw patients with a diagnosis of acute and/or
chronic back pain, 82.1% of them prescribed non-pharmacological, non-opioid
therapy to persons with acute and/or chronic back pain. Once the provider in this
study decided to initiate an opioid for treatment, 28.7% obtained a controlled
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substance agreement, 27.9% did not consult a prescription drug monitoring
database and 29.6% did obtain a urine drug screen. Providing education to the
patient regarding the hazards of opioid therapy is critical when prescribing
opioids, and this study revealed that of the providers that prescribed opioids
33.8% did not provide education to the patient.
Regional data from the Kansas Epidemiological Data Dashboard clearly
indicates that Southeast Kansas holds the highest number of opioid prescriptions
per 100 residents compared to the other regions in Kansas. This study shows that
53.3% of providers did not prescribe opioids for the treatment of acute or chronic
back pain, when an opioid was prescribed, more than 25% did not consult a
prescription drug monitoring database. This is an effective tool in identifying
potential opioid users, abusers and diverters and can be beneficial in guiding
providers in their decision making. More than 25% of the providers in this study
did obtain a controlled substance contract and/or a urine drug screen if an opioid
was prescribed which is another useful tool for identifying potential opioid
abusers or diverters.
Logic Model

The logic model designed for this study reveals how family practice
providers may contribute to the opioid epidemic through their prescribing
practices. The logic model also reveals how CDC recommendations regarding
treatment of chronic pain and opioid prescribing practices among primary care
providers can decrease the opioid epidemic with prescription drug monitoring
programs, controlled substance agreements and urine drug screenings. Utilization
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of the CDC guidelines can help providers identify potential opioid abusers and
diverters enabling them to appropriately treat the patient even if that requires
getting them assistance for an abuse problem. This study clearly indicates that the
logic model will improve patient outcomes through safe prescribing practices
among providers, increasing collaboration among providers, identifying potential
abusers sooner and increasing patient knowledge regarding the dangers of long
term opioid use.
Limitations

Possible limitations to this study include the limited number of clinics and
time that was studied which may not lead to a representative sample of the
information being sought. This study included only individuals with a diagnosis
of acute or chronic low back pain however; when looking at pain, all chronic pain
minus pain related to cancer could yield a difference in the outcome of the study.
Including only acute and or chronic back pain for this study leaves it open for
scrutiny on the reliability of regional comparison across the state of Kansas.
Medicine and treatment modalities are never stagnant, and knowledge in
medicine changes rapidly. The evolving nature of medicine may interfere with
new knowledge that is identified to date. Looking at regional data is an
informative indicator of how one region in Kansas compares to other regions
however; this study only looked at one set of clinics in Southeast Kansas, and a
better representative sample would need to include different clinics across all
regions across Kansas.
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Recommendations for Future Research

Future research for the opioid epidemic should look at clinics from all
areas in the state of Kansas and then compare that data to regional clinics which
would yield a better representation of regional data. Future research could also
look at providers and compare medical doctors to doctors of osteopathy to nurse
practitioners and physician assistants to identify those that may be overprescribing opioids. This data can then be looked at regionally to note differences
among providers and prescribing practicing, educational training among different
providers and the level of education received.
Study results reveal that providers may inadvertently be contributing to the
opioid epidemic due to lack of education regarding pain management during
formal education or because CDC guidelines have not been followed, leading to
inability to identify potential users and diverters of opioids.
There is no question that opioids are an effective treatment for acute and
or chronic back pain if conservative management fails, however; pain
management becomes challenging when the nation is currently faced with an
epidemic of enormous proportions due to drug use. When reimbursement is
linked to patient satisfaction, and opioids can and are used for legitimate
purposes, many providers are placed in a sticky situation regarding treatment
modalities. Providers become afraid to prescribe thereby under-prescribing for
fear of legal retribution or over-prescribing due to lack of knowledge in pain
management. Primary care providers are obligated to provide patients with
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appropriate care based on clinical practice guidelines however; these guidelines
may not correspond with patient satisfaction.
Conclusions

Chronic pain is an extensive challenging health problem that creates
enormous personal and socioeconomic costs (Peters, 2017). Unrelenting pain is
associated not just with physical ailments but emotional suffering, and individuals
often carry a diagnosis of depression due to chronic pain (Peters, 2017). Pain
management can only be successful in persons suffering with pain if they are
taught coping mechanisms allowing them to adapt to the devastating effects
(Peters, 2017).
Clinical practice guidelines are recommendations for providers to improve
patient outcomes by guiding their decision making for various treatments,
including those involving both acute and chronic back pain. The treatment of
pain either acute or chronic, is complex at best and needs to have a
multidisciplinary approach, but without proper education and a lack of pain
specialists, primary care providers have been forced to become pain management
specialists placing them in a precarious position of treating patients for complex
pain without appropriate education in treating pain. Even with appropriate
training in pain management for clinicians, there are several individuals that
obtain pain medications illegally which makes treating individuals with chronic
pain more challenging. This also requires clinicians to be more vigilant, if
clinicians are going to reduce the abuse and diversion of opioids while
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appropriately treating the patient and maintaining patient satisfaction (Couto,
2009).
Additional education for primary care providers would enhance their
knowledge about pain and how to appropriately manage pain, the pharmacology
of opioids and addiction (Volkow, 2011). The education is imperative for
primary care providers as research clearly indicate that primary care providers
prescribe more opioids than other practicing providers (Volkow, 2009). Formal
education in pain management should also include evidence-based
recommendations regarding treatments approaches for persons with current opioid
addictions and other comorbidities (Keller, 2012).
The clinical guidelines put forth by the CDC supplement other approaches
such as reinforcing evidence base for deterring and treating pain, minimizing
inequalities in pain management, enhancing service administration and
compensation and substantiating public and professional education (Dowell,
2016).
Summary

Pain is very much individualized and subjective, and how people cope
with pain is very diverse, making the treatment of noncancer related pain and
specifically acute and chronic back pain acute more complex and challenging.
Treatment for such pain should be a multidisciplinary approach with patient
engagement and improved education provided to the patient regarding different
types of pain, and the best methods for managing their pain. Most often acute and
chronic pain can be safely managed through conservative means if the provider
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can spend time with the patient providing much needed education. Providers
need to be well-versed in the different types of pain and how to treat as well.
Lack of provider education regarding the treatment of acute and/or chronic
back pain and chronic noncancer pain, lack of knowledge among lay persons
regarding the pathophysiology of pain, bringing about pain as the fifth vital sign,
advising people that they have the right to have their pain treated, and tying
reimbursement to patient satisfaction, created an unrealistic expectation for
individuals suffering from pain.
The first rule of medicine is to do no harm, and providers want what is
best for their patient however; the lack of education, lack of knowledge,
reimbursement, and providers wanting to keep patients satisfied have all
contributed to the current epidemic we are facing through over-prescribing or
under-prescribing. With unrealistic expectations for pain control, individuals
began to self-treatment with opioids contributing to the misuse and abuse of
opioids and the crisis facing our nation spun out of control.
Opioids have been shown to be effective; however due to the recent
epidemic plaguing this nation due to misuse and abuse, providers and patients
need to become better team members to combat this epidemic. Opioids will
always be around as they have a place in pain management, and misuse and abuse
will always occur to some extent; however, as providers it is our responsibility to
our patients, their families and the communities that we live in to protect them
from danger, and this includes the misuse of drugs, and as good stewards we are
responsible for doing our part to combat this epidemic through improved
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education of ourselves, our colleagues, education to patients and prescribing
practices that follow recommended guidelines that improve the safety of our
patients.
This epidemic did not begin over-night and it will not be fixed over-night
but if we want to combat this rapidly growing plague facing this nation, we must
begin now, and continue to be vigilant to protect our patients, families and
communities that we live in. Combatting this epidemic needs to be a team effort
and we need to start now.
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